Lunit receives $150M capital chip-in, doubles down on US market
Shareholders of KOSDAQ-listed Lunit have recently participated in the company’s recent capital raise, paying-in $150 million to fund its development of “next-generation” products and further expansion in the West. Meanwhile, the AI cancer diagnostics solutions…
Continue Reading